These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6633731)

  • 21. [Leukocyte depletion of blood products: a requirement for improvement of quality and safety].
    De Pauw BE; Van den Bos A
    Ned Tijdschr Geneeskd; 2000 Sep; 144(36):1754-6. PubMed ID: 10992905
    [No Abstract]   [Full Text] [Related]  

  • 22. [The importance of consensus in medicine].
    van Everdingen JJ; Touw PP; Klazinga NS; Casparie AF
    Ned Tijdschr Geneeskd; 1985 Oct; 129(40):1911-3. PubMed ID: 4069250
    [No Abstract]   [Full Text] [Related]  

  • 23. [External national quality control of blood group typing 1983-92. Significance for quality assurance in transfusion medicine].
    Heier HE; Kornstad L
    Tidsskr Nor Laegeforen; 1993 Oct; 113(25):3155-8. PubMed ID: 8273042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality improvement opportunities in blood banking and transfusion medicine.
    Brooks JP
    Clin Lab Med; 2008 Jun; 28(2):321-37, viii. PubMed ID: 18436074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood bank management of sickle cell patients at comprehensive sickle cell centers.
    Afenyi-Annan A; Willis MS; Konrad TR; Lottenberg R
    Transfusion; 2007 Nov; 47(11):2089-97. PubMed ID: 17958539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transfusion medicine--Scandinavian recommendations].
    Jørgensen J; Jensson O; Eklund J; Kornstad L; Messeter L
    Nord Med; 1994; 109(2):61-3. PubMed ID: 8121792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukoreduction of the blood supply in Rhode Island.
    Sweeney JD
    Med Health R I; 1998 Dec; 81(12):386-91. PubMed ID: 9884537
    [No Abstract]   [Full Text] [Related]  

  • 28. Cytapheresis practice: recommendations of New York Cytapheresis Task Force.
    Kalter RD; Levine M; Pindyck J; Reich L; Reiss R; Spivack M; Sussman L; Wenz B
    N Y State J Med; 1982 Oct; 82(11):1597-1600. PubMed ID: 6959013
    [No Abstract]   [Full Text] [Related]  

  • 29. Haemovigilance and transfusion safety in France.
    Rouger P; Noizat-Pirenne F; Le Pennec PY
    Vox Sang; 2000; 78 Suppl 2():287-9. PubMed ID: 10938971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogen inactivation: making decisions about new technologies. Report of a consensus conference.
    Klein HG; Anderson D; Bernardi MJ; Cable R; Carey W; Hoch JS; Robitaille N; Sivilotti ML; Smaill F
    Transfusion; 2007 Dec; 47(12):2338-47. PubMed ID: 18036075
    [No Abstract]   [Full Text] [Related]  

  • 31. [Quality assurance in transfusion medicine from an international viewpoint].
    Gänshirt KH
    Beitr Infusionsther Transfusionsmed; 1994; 32():382-7. PubMed ID: 9480129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total quality management in blood transfusion.
    Smit-Sibinga CT
    Vox Sang; 2000; 78 Suppl 2():281-6. PubMed ID: 10938970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogen inactivation: making decisions about new technologies - preliminary report of a consensus conference.
    Klein HG; Anderson D; Bernardi MJ; Cable R; Carey W; Hoch JS; Robitaille N; Sivilotti ML; Smaill F
    Vox Sang; 2007 Aug; 93(2):179-82. PubMed ID: 17683364
    [No Abstract]   [Full Text] [Related]  

  • 34. [Quality control in an immunohematology laboratory in the Croatian Transfusion Service].
    Sarlija D; Balija M; Bosanac I; Hundrić-Haspl Z; Tomicić M; Grgicević D
    Lijec Vjesn; 1995; 117(1-2):19-23. PubMed ID: 7651064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines for compatibility procedures in blood transfusion laboratories.
    Chapman JF; Elliott C; Knowles SM; Milkins CE; Poole GD;
    Transfus Med; 2004 Feb; 14(1):59-73. PubMed ID: 15043595
    [No Abstract]   [Full Text] [Related]  

  • 36. The precautionary principle and emerging biologic risks: lessons from human immunodeficiency virus in blood products.
    Stoto MA
    Semin Hematol; 2006 Apr; 43(2 Suppl 3):S10-2. PubMed ID: 16631821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The application of the precautionary principle to the blood system: the Canadian blood system's vCJD donor deferral policy.
    Wilson K; Wilson M; Hébert PC; Graham I
    Transfus Med Rev; 2003 Apr; 17(2):89-94. PubMed ID: 12733102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the gift still good? Examining the politics and regulation of blood safety in the European Union.
    Farrell AM
    Med Law Rev; 2006; 14(2):155-79. PubMed ID: 16831820
    [No Abstract]   [Full Text] [Related]  

  • 39. How I minimize mistransfusion risk in my hospital.
    Aubuchon JP
    Transfusion; 2006 Jul; 46(7):1085-9. PubMed ID: 16836553
    [No Abstract]   [Full Text] [Related]  

  • 40. Randomized prospective trial for blood transfusion during adult cardiopulmonary bypass surgery.
    Shuhaiber JH
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1200-1. PubMed ID: 15867816
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.